Investors Grab ITCI Even Lower Than Its Secondary Stock Offering
April 19, 2024 at 10:07 AM EDT
Looking back to 2 days ago, Intra-Cellular Therapies Inc (ITCI) priced a 6,849,316 share secondary stock offering at $73.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..